News
Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of ...
A very different prediction comes by way of Chris Gibson, the CEO of AI-powered biotech Recursion ... to work on, it begins with cells instead. Recursion then studies those cells using imaging ...
Recursion then takes a microscopic snapshot of the reaction and uses machine-learning software trained to spot the sick and healthy cells to sort out what works. “It lets you operate without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results